nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—GABRR3—peripheral nervous system—Parkinson's disease	0.02	0.045	CbGeAlD
Triazolam—GABRR2—peripheral nervous system—Parkinson's disease	0.0173	0.039	CbGeAlD
Triazolam—GABRR1—peripheral nervous system—Parkinson's disease	0.0167	0.0375	CbGeAlD
Triazolam—GABRR3—nerve—Parkinson's disease	0.0156	0.0351	CbGeAlD
Triazolam—GABRQ—nerve—Parkinson's disease	0.0156	0.0351	CbGeAlD
Triazolam—GABRR2—nerve—Parkinson's disease	0.0135	0.0304	CbGeAlD
Triazolam—GABRR1—nerve—Parkinson's disease	0.013	0.0293	CbGeAlD
Triazolam—GABRA6—hindbrain—Parkinson's disease	0.0081	0.0182	CbGeAlD
Triazolam—GABRQ—forebrain—Parkinson's disease	0.00646	0.0145	CbGeAlD
Triazolam—GABRB2—hindbrain—Parkinson's disease	0.00596	0.0134	CbGeAlD
Triazolam—GABRA2—hindbrain—Parkinson's disease	0.00545	0.0123	CbGeAlD
Triazolam—GABRR1—forebrain—Parkinson's disease	0.00539	0.0121	CbGeAlD
Triazolam—GABRA1—hindbrain—Parkinson's disease	0.00527	0.0119	CbGeAlD
Triazolam—GABRD—forebrain—Parkinson's disease	0.00468	0.0105	CbGeAlD
Triazolam—GABRA6—brainstem—Parkinson's disease	0.00464	0.0104	CbGeAlD
Triazolam—GABRG1—forebrain—Parkinson's disease	0.00451	0.0101	CbGeAlD
Triazolam—GABRA5—forebrain—Parkinson's disease	0.00435	0.00978	CbGeAlD
Triazolam—GABRA4—forebrain—Parkinson's disease	0.00394	0.00888	CbGeAlD
Triazolam—GABRQ—head—Parkinson's disease	0.0037	0.00832	CbGeAlD
Triazolam—GABRR3—head—Parkinson's disease	0.0037	0.00832	CbGeAlD
Triazolam—GABRQ—nervous system—Parkinson's disease	0.00351	0.00789	CbGeAlD
Triazolam—GABRR3—nervous system—Parkinson's disease	0.00351	0.00789	CbGeAlD
Triazolam—GABRB2—brainstem—Parkinson's disease	0.00342	0.00769	CbGeAlD
Triazolam—GABRD—medulla oblongata—Parkinson's disease	0.00338	0.00761	CbGeAlD
Triazolam—GABRQ—central nervous system—Parkinson's disease	0.00337	0.00759	CbGeAlD
Triazolam—GABRB2—forebrain—Parkinson's disease	0.0033	0.00742	CbGeAlD
Triazolam—GABRG2—forebrain—Parkinson's disease	0.0033	0.00742	CbGeAlD
Triazolam—GABRG1—medulla oblongata—Parkinson's disease	0.00326	0.00733	CbGeAlD
Triazolam—GABRG3—head—Parkinson's disease	0.00324	0.00729	CbGeAlD
Triazolam—GABRR2—head—Parkinson's disease	0.00321	0.00721	CbGeAlD
Triazolam—GABRB1—medulla oblongata—Parkinson's disease	0.00316	0.00711	CbGeAlD
Triazolam—TSPO—embryo—Parkinson's disease	0.00316	0.0071	CbGeAlD
Triazolam—GABRA2—brainstem—Parkinson's disease	0.00312	0.00703	CbGeAlD
Triazolam—GABRD—midbrain—Parkinson's disease	0.00309	0.00696	CbGeAlD
Triazolam—GABRR1—head—Parkinson's disease	0.00309	0.00694	CbGeAlD
Triazolam—GABRG3—nervous system—Parkinson's disease	0.00307	0.00691	CbGeAlD
Triazolam—GABRR2—nervous system—Parkinson's disease	0.00304	0.00684	CbGeAlD
Triazolam—GABRA1—brainstem—Parkinson's disease	0.00302	0.00679	CbGeAlD
Triazolam—GABRA2—forebrain—Parkinson's disease	0.00301	0.00678	CbGeAlD
Triazolam—GABRG1—midbrain—Parkinson's disease	0.00298	0.0067	CbGeAlD
Triazolam—GABRG3—central nervous system—Parkinson's disease	0.00296	0.00665	CbGeAlD
Triazolam—GABRR1—nervous system—Parkinson's disease	0.00293	0.00658	CbGeAlD
Triazolam—GABRA1—forebrain—Parkinson's disease	0.00291	0.00656	CbGeAlD
Triazolam—GABRG1—spinal cord—Parkinson's disease	0.0029	0.00654	CbGeAlD
Triazolam—TSPO—brainstem—Parkinson's disease	0.00289	0.00651	CbGeAlD
Triazolam—GABRB1—midbrain—Parkinson's disease	0.00289	0.0065	CbGeAlD
Triazolam—GABRR2—cerebellum—Parkinson's disease	0.00286	0.00644	CbGeAlD
Triazolam—GABRR1—central nervous system—Parkinson's disease	0.00282	0.00634	CbGeAlD
Triazolam—GABRB1—spinal cord—Parkinson's disease	0.00282	0.00634	CbGeAlD
Triazolam—TSPO—forebrain—Parkinson's disease	0.00279	0.00628	CbGeAlD
Triazolam—GABRD—head—Parkinson's disease	0.00268	0.00603	CbGeAlD
Triazolam—GABRQ—brain—Parkinson's disease	0.00268	0.00603	CbGeAlD
Triazolam—GABRG1—head—Parkinson's disease	0.00258	0.00581	CbGeAlD
Triazolam—GABRA6—head—Parkinson's disease	0.00257	0.00577	CbGeAlD
Triazolam—GABRD—nervous system—Parkinson's disease	0.00254	0.00572	CbGeAlD
Triazolam—GABRB3—forebrain—Parkinson's disease	0.00253	0.0057	CbGeAlD
Triazolam—GABRB1—head—Parkinson's disease	0.0025	0.00563	CbGeAlD
Triazolam—GABRA5—head—Parkinson's disease	0.00249	0.0056	CbGeAlD
Triazolam—GABRD—central nervous system—Parkinson's disease	0.00245	0.00551	CbGeAlD
Triazolam—GABRG1—nervous system—Parkinson's disease	0.00245	0.00551	CbGeAlD
Triazolam—GABRA6—nervous system—Parkinson's disease	0.00243	0.00547	CbGeAlD
Triazolam—GABRD—cerebellum—Parkinson's disease	0.00239	0.00538	CbGeAlD
Triazolam—GABRB2—medulla oblongata—Parkinson's disease	0.00238	0.00536	CbGeAlD
Triazolam—GABRG2—medulla oblongata—Parkinson's disease	0.00238	0.00536	CbGeAlD
Triazolam—GABRB1—nervous system—Parkinson's disease	0.00237	0.00534	CbGeAlD
Triazolam—GABRA5—nervous system—Parkinson's disease	0.00236	0.00531	CbGeAlD
Triazolam—TSPO—cardiovascular system—Parkinson's disease	0.00236	0.00531	CbGeAlD
Triazolam—GABRG1—central nervous system—Parkinson's disease	0.00236	0.0053	CbGeAlD
Triazolam—GABRG3—brain—Parkinson's disease	0.00235	0.00528	CbGeAlD
Triazolam—GABRA6—central nervous system—Parkinson's disease	0.00234	0.00527	CbGeAlD
Triazolam—GABRA3—head—Parkinson's disease	0.00232	0.00521	CbGeAlD
Triazolam—GABRG1—cerebellum—Parkinson's disease	0.0023	0.00518	CbGeAlD
Triazolam—GABRA6—cerebellum—Parkinson's disease	0.00229	0.00515	CbGeAlD
Triazolam—GABRB1—central nervous system—Parkinson's disease	0.00228	0.00514	CbGeAlD
Triazolam—GABRA5—central nervous system—Parkinson's disease	0.00227	0.00511	CbGeAlD
Triazolam—GABRA4—head—Parkinson's disease	0.00226	0.00508	CbGeAlD
Triazolam—GABRP—head—Parkinson's disease	0.00224	0.00505	CbGeAlD
Triazolam—GABRR1—brain—Parkinson's disease	0.00224	0.00503	CbGeAlD
Triazolam—GABRB1—cerebellum—Parkinson's disease	0.00223	0.00502	CbGeAlD
Triazolam—GABRA3—nervous system—Parkinson's disease	0.0022	0.00494	CbGeAlD
Triazolam—GABRG2—midbrain—Parkinson's disease	0.00218	0.0049	CbGeAlD
Triazolam—GABRB2—midbrain—Parkinson's disease	0.00218	0.0049	CbGeAlD
Triazolam—GABRA4—nervous system—Parkinson's disease	0.00214	0.00482	CbGeAlD
Triazolam—GABRB2—spinal cord—Parkinson's disease	0.00213	0.00478	CbGeAlD
Triazolam—GABRG2—spinal cord—Parkinson's disease	0.00213	0.00478	CbGeAlD
Triazolam—GABRA3—central nervous system—Parkinson's disease	0.00212	0.00476	CbGeAlD
Triazolam—GABRA1—medulla oblongata—Parkinson's disease	0.0021	0.00474	CbGeAlD
Triazolam—GABRA4—central nervous system—Parkinson's disease	0.00206	0.00464	CbGeAlD
Triazolam—TSPO—medulla oblongata—Parkinson's disease	0.00202	0.00454	CbGeAlD
Triazolam—GABRA4—cerebellum—Parkinson's disease	0.00201	0.00453	CbGeAlD
Triazolam—GABRD—brain—Parkinson's disease	0.00194	0.00437	CbGeAlD
Triazolam—GABRA1—midbrain—Parkinson's disease	0.00192	0.00433	CbGeAlD
Triazolam—GABRB2—head—Parkinson's disease	0.00189	0.00425	CbGeAlD
Triazolam—GABRG2—head—Parkinson's disease	0.00189	0.00425	CbGeAlD
Triazolam—GABRA1—spinal cord—Parkinson's disease	0.00188	0.00422	CbGeAlD
Triazolam—GABRG1—brain—Parkinson's disease	0.00187	0.00421	CbGeAlD
Triazolam—GABRA6—brain—Parkinson's disease	0.00186	0.00418	CbGeAlD
Triazolam—TSPO—midbrain—Parkinson's disease	0.00184	0.00415	CbGeAlD
Triazolam—GABRB3—medulla oblongata—Parkinson's disease	0.00183	0.00412	CbGeAlD
Triazolam—GABRB1—brain—Parkinson's disease	0.00181	0.00408	CbGeAlD
Triazolam—GABRA5—brain—Parkinson's disease	0.0018	0.00406	CbGeAlD
Triazolam—TSPO—spinal cord—Parkinson's disease	0.0018	0.00405	CbGeAlD
Triazolam—GABRB2—nervous system—Parkinson's disease	0.00179	0.00403	CbGeAlD
Triazolam—GABRG2—nervous system—Parkinson's disease	0.00179	0.00403	CbGeAlD
Triazolam—GABRA2—head—Parkinson's disease	0.00173	0.00388	CbGeAlD
Triazolam—GABRG2—central nervous system—Parkinson's disease	0.00172	0.00388	CbGeAlD
Triazolam—GABRB2—central nervous system—Parkinson's disease	0.00172	0.00388	CbGeAlD
Triazolam—GABRE—head—Parkinson's disease	0.00171	0.00385	CbGeAlD
Triazolam—GABRG2—cerebellum—Parkinson's disease	0.00169	0.00379	CbGeAlD
Triazolam—GABRB2—cerebellum—Parkinson's disease	0.00169	0.00379	CbGeAlD
Triazolam—GABRA3—brain—Parkinson's disease	0.00168	0.00378	CbGeAlD
Triazolam—GABRB3—midbrain—Parkinson's disease	0.00167	0.00376	CbGeAlD
Triazolam—GABRA1—head—Parkinson's disease	0.00167	0.00375	CbGeAlD
Triazolam—GABRA4—brain—Parkinson's disease	0.00164	0.00368	CbGeAlD
Triazolam—GABRA2—nervous system—Parkinson's disease	0.00164	0.00368	CbGeAlD
Triazolam—GABRB3—spinal cord—Parkinson's disease	0.00163	0.00367	CbGeAlD
Triazolam—GABRE—nervous system—Parkinson's disease	0.00162	0.00365	CbGeAlD
Triazolam—TSPO—head—Parkinson's disease	0.0016	0.0036	CbGeAlD
Triazolam—GABRA1—nervous system—Parkinson's disease	0.00158	0.00356	CbGeAlD
Triazolam—GABRA2—central nervous system—Parkinson's disease	0.00158	0.00355	CbGeAlD
Triazolam—GABRE—central nervous system—Parkinson's disease	0.00156	0.00352	CbGeAlD
Triazolam—GABRA2—cerebellum—Parkinson's disease	0.00154	0.00347	CbGeAlD
Triazolam—GABRA1—central nervous system—Parkinson's disease	0.00152	0.00343	CbGeAlD
Triazolam—TSPO—nervous system—Parkinson's disease	0.00151	0.00341	CbGeAlD
Triazolam—GABRA1—cerebellum—Parkinson's disease	0.00149	0.00335	CbGeAlD
Triazolam—TSPO—central nervous system—Parkinson's disease	0.00146	0.00328	CbGeAlD
Triazolam—GABRB3—head—Parkinson's disease	0.00145	0.00326	CbGeAlD
Triazolam—CYP2C9—cardiovascular system—Parkinson's disease	0.00144	0.00324	CbGeAlD
Triazolam—TSPO—cerebellum—Parkinson's disease	0.00143	0.00321	CbGeAlD
Triazolam—GABRB3—nervous system—Parkinson's disease	0.00138	0.0031	CbGeAlD
Triazolam—GABRG2—brain—Parkinson's disease	0.00137	0.00308	CbGeAlD
Triazolam—GABRB2—brain—Parkinson's disease	0.00137	0.00308	CbGeAlD
Triazolam—GABRB3—central nervous system—Parkinson's disease	0.00132	0.00298	CbGeAlD
Triazolam—Chlorprothixene—DRD3—Parkinson's disease	0.00129	0.11	CrCbGaD
Triazolam—GABRB3—cerebellum—Parkinson's disease	0.00129	0.00291	CbGeAlD
Triazolam—Chlorprothixene—DRD1—Parkinson's disease	0.00127	0.108	CrCbGaD
Triazolam—GABRA2—brain—Parkinson's disease	0.00125	0.00281	CbGeAlD
Triazolam—Clonazepam—CYP2E1—Parkinson's disease	0.00125	0.107	CrCbGaD
Triazolam—GABRE—brain—Parkinson's disease	0.00124	0.00279	CbGeAlD
Triazolam—GABRA1—brain—Parkinson's disease	0.00121	0.00272	CbGeAlD
Triazolam—TSPO—brain—Parkinson's disease	0.00116	0.00261	CbGeAlD
Triazolam—GABRB3—brain—Parkinson's disease	0.00105	0.00237	CbGeAlD
Triazolam—Flunitrazepam—CYP2E1—Parkinson's disease	0.001	0.0856	CrCbGaD
Triazolam—Chlordiazepoxide—CYP2D6—Parkinson's disease	0.00095	0.081	CrCbGaD
Triazolam—Chlorprothixene—DRD2—Parkinson's disease	0.000896	0.0764	CrCbGaD
Triazolam—Flurazepam—CYP2E1—Parkinson's disease	0.000805	0.0687	CrCbGaD
Triazolam—CYP2C8—brain—Parkinson's disease	0.000795	0.00179	CbGeAlD
Triazolam—Midazolam—CYP2E1—Parkinson's disease	0.000747	0.0637	CrCbGaD
Triazolam—CYP3A4—nervous system—Parkinson's disease	0.000704	0.00158	CbGeAlD
Triazolam—Chlorprothixene—HTR2A—Parkinson's disease	0.000692	0.0591	CrCbGaD
Triazolam—CYP3A4—central nervous system—Parkinson's disease	0.000678	0.00153	CbGeAlD
Triazolam—Diazepam—CYP2E1—Parkinson's disease	0.00064	0.0546	CrCbGaD
Triazolam—Clobazam—ABCB1—Parkinson's disease	0.000575	0.049	CrCbGaD
Triazolam—Chlorprothixene—ABCB1—Parkinson's disease	0.000452	0.0386	CrCbGaD
Triazolam—Flurazepam—ABCB1—Parkinson's disease	0.000422	0.036	CrCbGaD
Triazolam—Midazolam—ABCB1—Parkinson's disease	0.000391	0.0334	CrCbGaD
Triazolam—Diazepam—ABCB1—Parkinson's disease	0.000335	0.0286	CrCbGaD
Triazolam—CYP3A5—Biological oxidations—MAOA—Parkinson's disease	0.0002	0.000368	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—COMT—Parkinson's disease	0.000199	0.000365	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000199	0.000365	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000198	0.000364	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000197	0.000363	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000196	0.000361	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000196	0.000361	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—CASP3—Parkinson's disease	0.000195	0.000358	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000193	0.000356	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000193	0.000354	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000191	0.00035	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000188	0.000346	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000188	0.000346	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000187	0.000345	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000187	0.000343	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000186	0.000342	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000185	0.00034	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—GSTM1—Parkinson's disease	0.000184	0.000339	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000184	0.000338	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000183	0.000336	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000183	0.000336	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000182	0.000334	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ND3—Parkinson's disease	0.000181	0.000332	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MCCC1—Parkinson's disease	0.000181	0.000332	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00018	0.000332	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000179	0.000329	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000178	0.000327	CbGpPWpGaD
Triazolam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000175	0.000322	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—COMT—Parkinson's disease	0.000175	0.000321	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—GSTP1—Parkinson's disease	0.000174	0.000319	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—MAOA—Parkinson's disease	0.000173	0.000319	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000173	0.000318	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—COMT—Parkinson's disease	0.000172	0.000317	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.000171	0.000315	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000171	0.000315	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000171	0.000314	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—OMD—Parkinson's disease	0.00017	0.000313	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—TALDO1—Parkinson's disease	0.00017	0.000313	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000169	0.000311	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000166	0.000306	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000163	0.000299	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000161	0.000297	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NDUFB11—Parkinson's disease	0.000161	0.000296	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—GSTM1—Parkinson's disease	0.00016	0.000294	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000159	0.000292	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000158	0.000291	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000157	0.00029	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000157	0.000289	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000157	0.000289	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000157	0.000288	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000156	0.000288	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000155	0.000286	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000155	0.000285	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GCH1—Parkinson's disease	0.000154	0.000283	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000153	0.000281	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000153	0.000281	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000152	0.000279	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000152	0.000279	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000151	0.000277	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000149	0.000274	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000149	0.000274	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000149	0.000273	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000147	0.00027	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000146	0.000268	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000144	0.000266	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000143	0.000263	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000143	0.000262	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000142	0.000261	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000141	0.00026	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000141	0.000259	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.00014	0.000258	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000139	0.000256	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—DBH—Parkinson's disease	0.000137	0.000252	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—FBP1—Parkinson's disease	0.000137	0.000252	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GBA—Parkinson's disease	0.000137	0.000252	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000136	0.00025	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000132	0.000243	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MCCC1—Parkinson's disease	0.000131	0.00024	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ND3—Parkinson's disease	0.000131	0.00024	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00013	0.00024	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00013	0.000239	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.00013	0.000239	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00013	0.000238	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000128	0.000236	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000127	0.000234	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000127	0.000233	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000127	0.000233	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000125	0.00023	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000124	0.000229	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000124	0.000229	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000124	0.000227	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TALDO1—Parkinson's disease	0.000123	0.000226	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—OMD—Parkinson's disease	0.000123	0.000226	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000122	0.000225	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000122	0.000224	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000122	0.000223	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00012	0.000221	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000119	0.000219	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	0.000116	0.000214	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000114	0.00021	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MCCC1—Parkinson's disease	0.000113	0.000208	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ND3—Parkinson's disease	0.000113	0.000208	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000113	0.000208	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000112	0.000205	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GCH1—Parkinson's disease	0.000111	0.000204	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000109	0.0002	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TALDO1—Parkinson's disease	0.000106	0.000196	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—OMD—Parkinson's disease	0.000106	0.000196	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000104	0.000192	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NDUFB11—Parkinson's disease	0.000101	0.000186	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—DDC—Parkinson's disease	0.000101	0.000185	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GBA—Parkinson's disease	9.9e-05	0.000182	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—FBP1—Parkinson's disease	9.9e-05	0.000182	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—DBH—Parkinson's disease	9.9e-05	0.000182	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	9.78e-05	0.00018	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GCH1—Parkinson's disease	9.63e-05	0.000177	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTA4—Parkinson's disease	9.5e-05	0.000175	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—COMT—Parkinson's disease	9.37e-05	0.000172	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	9.33e-05	0.000171	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	9.3e-05	0.000171	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	9.24e-05	0.00017	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MCCC1—Parkinson's disease	9.21e-05	0.000169	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ND3—Parkinson's disease	9.21e-05	0.000169	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	9.21e-05	0.000169	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	9.2e-05	0.000169	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	8.68e-05	0.00016	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TALDO1—Parkinson's disease	8.66e-05	0.000159	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—OMD—Parkinson's disease	8.66e-05	0.000159	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GBA—Parkinson's disease	8.58e-05	0.000158	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—FBP1—Parkinson's disease	8.58e-05	0.000158	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—DBH—Parkinson's disease	8.58e-05	0.000158	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	8.57e-05	0.000158	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PLA2G6—Parkinson's disease	8.55e-05	0.000157	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MAOB—Parkinson's disease	8.47e-05	0.000156	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	8.45e-05	0.000155	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	8.21e-05	0.000151	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GCH1—Parkinson's disease	7.83e-05	0.000144	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—DDC—Parkinson's disease	7.27e-05	0.000134	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	7.07e-05	0.00013	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GBA—Parkinson's disease	6.98e-05	0.000128	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—DBH—Parkinson's disease	6.98e-05	0.000128	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—FBP1—Parkinson's disease	6.98e-05	0.000128	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTA4—Parkinson's disease	6.87e-05	0.000126	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—DDC—Parkinson's disease	6.3e-05	0.000116	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	6.29e-05	0.000116	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	6.18e-05	0.000114	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CTGF—Parkinson's disease	6.18e-05	0.000114	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MAOB—Parkinson's disease	6.12e-05	0.000113	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MCCC1—Parkinson's disease	6.08e-05	0.000112	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ND3—Parkinson's disease	6.08e-05	0.000112	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTA4—Parkinson's disease	5.95e-05	0.000109	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	5.87e-05	0.000108	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	5.75e-05	0.000106	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TALDO1—Parkinson's disease	5.71e-05	0.000105	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—OMD—Parkinson's disease	5.71e-05	0.000105	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NQO1—Parkinson's disease	5.69e-05	0.000105	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—TH—Parkinson's disease	5.61e-05	0.000103	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	5.42e-05	9.96e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYCS—Parkinson's disease	5.38e-05	9.9e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	5.35e-05	9.84e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MAOB—Parkinson's disease	5.3e-05	9.75e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GCH1—Parkinson's disease	5.17e-05	9.5e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—DDC—Parkinson's disease	5.12e-05	9.42e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	5.04e-05	9.27e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTA4—Parkinson's disease	4.84e-05	8.9e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.78e-05	8.79e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—COMT—Parkinson's disease	4.77e-05	8.77e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTP1—Parkinson's disease	4.75e-05	8.73e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MAOA—Parkinson's disease	4.73e-05	8.71e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—HMOX1—Parkinson's disease	4.68e-05	8.61e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GBA—Parkinson's disease	4.6e-05	8.47e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—FBP1—Parkinson's disease	4.6e-05	8.47e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—DBH—Parkinson's disease	4.6e-05	8.47e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	4.55e-05	8.36e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ABCB1—Parkinson's disease	4.49e-05	8.26e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CTGF—Parkinson's disease	4.46e-05	8.21e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTM1—Parkinson's disease	4.36e-05	8.02e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	4.36e-05	8.01e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MAOB—Parkinson's disease	4.31e-05	7.93e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GPX1—Parkinson's disease	4.18e-05	7.68e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	4.16e-05	7.65e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NQO1—Parkinson's disease	4.11e-05	7.56e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.11e-05	7.55e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TH—Parkinson's disease	4.05e-05	7.45e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	3.94e-05	7.24e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYCS—Parkinson's disease	3.89e-05	7.16e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CTGF—Parkinson's disease	3.87e-05	7.11e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MTHFR—Parkinson's disease	3.85e-05	7.09e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	3.6e-05	6.62e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOE—Parkinson's disease	3.59e-05	6.6e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NQO1—Parkinson's disease	3.56e-05	6.55e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TH—Parkinson's disease	3.51e-05	6.46e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—COMT—Parkinson's disease	3.45e-05	6.34e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTP1—Parkinson's disease	3.43e-05	6.31e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MAOA—Parkinson's disease	3.42e-05	6.29e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HMOX1—Parkinson's disease	3.38e-05	6.22e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—DDC—Parkinson's disease	3.38e-05	6.21e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYCS—Parkinson's disease	3.37e-05	6.2e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCB1—Parkinson's disease	3.25e-05	5.97e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	3.21e-05	5.89e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA4—Parkinson's disease	3.19e-05	5.87e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTM1—Parkinson's disease	3.15e-05	5.8e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CTGF—Parkinson's disease	3.15e-05	5.79e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—INS—Parkinson's disease	3.07e-05	5.64e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GPX1—Parkinson's disease	3.02e-05	5.55e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—COMT—Parkinson's disease	2.99e-05	5.49e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTP1—Parkinson's disease	2.97e-05	5.46e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MAOA—Parkinson's disease	2.96e-05	5.45e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	2.93e-05	5.39e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HMOX1—Parkinson's disease	2.93e-05	5.39e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NQO1—Parkinson's disease	2.9e-05	5.33e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.87e-05	5.28e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TH—Parkinson's disease	2.86e-05	5.25e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.84e-05	5.23e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCB1—Parkinson's disease	2.81e-05	5.17e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MTHFR—Parkinson's disease	2.79e-05	5.12e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYCS—Parkinson's disease	2.74e-05	5.04e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTM1—Parkinson's disease	2.73e-05	5.02e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GPX1—Parkinson's disease	2.61e-05	4.81e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOE—Parkinson's disease	2.59e-05	4.77e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—COMT—Parkinson's disease	2.43e-05	4.47e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTP1—Parkinson's disease	2.42e-05	4.45e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MTHFR—Parkinson's disease	2.41e-05	4.44e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MAOA—Parkinson's disease	2.41e-05	4.44e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HMOX1—Parkinson's disease	2.38e-05	4.38e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCB1—Parkinson's disease	2.29e-05	4.21e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOE—Parkinson's disease	2.25e-05	4.13e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTM1—Parkinson's disease	2.22e-05	4.09e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—INS—Parkinson's disease	2.22e-05	4.07e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GPX1—Parkinson's disease	2.13e-05	3.91e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.11e-05	3.89e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.08e-05	3.82e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.96e-05	3.61e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.93e-05	3.56e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—INS—Parkinson's disease	1.92e-05	3.53e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.91e-05	3.52e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TH—Parkinson's disease	1.88e-05	3.46e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOE—Parkinson's disease	1.83e-05	3.36e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.81e-05	3.33e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—COMT—Parkinson's disease	1.6e-05	2.95e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.59e-05	2.93e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.59e-05	2.93e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.57e-05	2.89e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—INS—Parkinson's disease	1.56e-05	2.87e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.51e-05	2.78e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.47e-05	2.69e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.4e-05	2.58e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.3e-05	2.38e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOE—Parkinson's disease	1.21e-05	2.22e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—INS—Parkinson's disease	1.03e-05	1.89e-05	CbGpPWpGaD
